ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Donor Lung Preservation With the Organ Care System® Promotes a Tissue Protective and Anti-Inflammatory Response During Transplantation

B. Wiegmann,1 C. Falk,2 M. Seyda,2 C. Neudörfl,2 A. Akhdar,2 C. Kühn,1 I. Tudorache,1 M. Avsar,1 A. Haverich,1 G. Warnecke.1

1Department for Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
2Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany.

Meeting: 2015 American Transplant Congress

Abstract number: C247

Keywords: Lung preservation, Lung transplantation, Machine preservation, T cells

Session Information

Session Name: Poster Session C: Translational Biomarkers and Immune Monitoring

Session Type: Poster Session

Date: Monday, May 4, 2015

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Objectives

Within INSPIRE trial standard cold storage (SOC) is compared to normothermic, ventilated donor lung preservation (Organ-Care-System®, OCS). As lung preservation may influence immune mediators (IM), thereby clinical outcome, lympohcyte subsets and cytokines released from lungs into perfusion solutions (PS) and peripheral blood (PB) were analysed.

Methods

From 31 OCS and 23 SOC patients, IM and T cell subsets were analysed in PS and PB by multiplex and FACS-analyses. Clinical outcome, donor and recipient demographics were assessed.

Results

Clinical evaluation revealed (OCS vs SOC): mean donor age 44 vs. 48 years, mean recipient age 50 vs. 50 years, underlying diagnosis: idiopathic fibrosis (n=15 vs n=11), cystic fibrosis (n=7 vs n=6), idiopathic pulmonary hypertension (n=2 vs n=2) and emphysema (n=7 vs n=4). Mean cross clamp times for right (434 vs 421 min) and left lung (563 vs. 537) did not differ significantly. Higher %predicted FEV1 at discharge was recorded in the OCS group (68% vs 60%), as well as higher paO2/FiO2 ratio at T0 (367 vs 321). Lymphocytes were mobilized into PS in both groups with significant differences of higher proportions of CD3+CD8+ T cells and CD3+CD4+CD56+ T helper cells in OCS. Presence of CD56+ Th cells in OCS PS correlated with Th2 cytokines, which were dominated by IL-4, IL-10, IL-31 and sCD40L as activation markers and induced by IL-33. This anti-inflammatory Th2 response maintained also in OCS recipients suppressing IL-6 mediated inflammation post Tx. Since high IL-6 levels in plasma of SOC patients post Tx negatively correlated with PaO2/FiO2 ratio, suppression of IL-6 by Th2 cells and their cytokines represents an important mechanism for improved immune status of OCS preserved lungs.

Conclusion

Immediate OCS preservation generates an anti-inflammatory Th2 milieu, induced by IL-33 production of lung epithelial cells and suppresses inflammation after Tx. It also changes lymphocyte and cytokine release from the lungs towards a tissue-protective milieu associated with lower immunogenicity seen by their different T cell compositions. Since several factors correlated with lung function, they may represent biomarker candidates for clinical outcome.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Wiegmann B, Falk C, Seyda M, Neudörfl C, Akhdar A, Kühn C, Tudorache I, Avsar M, Haverich A, Warnecke G. Donor Lung Preservation With the Organ Care System® Promotes a Tissue Protective and Anti-Inflammatory Response During Transplantation [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/donor-lung-preservation-with-the-organ-care-system-promotes-a-tissue-protective-and-anti-inflammatory-response-during-transplantation/. Accessed June 7, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences